OMEROS CORP Operating Loss Carryforwards
OMEROS CORP (OMER) had Operating Loss Carryforwards of $513.20 million as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2019-03-01
- 2018-12-31: Operating Loss Carryforwards $513.20M.
- 2017-12-31: Operating Loss Carryforwards $414.50M.
- 2016-12-31: Operating Loss Carryforwards $378.90M.
- 2015-12-31: Operating Loss Carryforwards $325.90M.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2018-12-31 | $513.20M 10-K · filed 2019-03-01 | |
| 2017-12-31 | $414.50M 10-K · filed 2019-03-01 | |
| 2016-12-31 | $378.90M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $325.90M 10-K · filed 2017-03-16 | |
| 2014-12-31 | $264.10M 10-K · filed 2016-03-15 | |
| 2013-12-31 | $205.90M 10-K · filed 2015-03-16 | |
| 2012-12-31 | $177.00M 10-K · filed 2014-03-13 | $173.90M 10-K · filed 2013-03-18 |
| 2011-12-31 | $143.80M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |